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ABSTRACT
The present study was carried out to evaluate the hepatoprotective role of leaf extracts of Azadirachta 
indica A. Juss. Hepatoprotective activities of ethanolic and aqueous extracts of A. indica were 
examined against carbon tetrachloride induced liver damage in mice using silymarin as control. 
Enzyme activities of Serum Glutamate Oxaloacetate Transaminase (SGOT), Serum Glutamate 
Pyruvate Transaminase (SGPT) and Alkaline Phosphatase (ALP) were analyzed. Phytochemical leaf 
extracts of A. indica exhibited significant hepatoprotective activity. Ethanolic and aqueous leaf extracts 
of A. indica exhibited moderate activity over carbon tetrachloride treated animals. Results confirm the 
traditional - ethnomedicinal use of A. indica as a potential source of hepatoprotective agent.
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INTRODUCTION  
            Medicinal plants are part and parcel of human, since the dawn of civilization. In India they 
form the backbone of several indigenous traditional systems of medicine. In recent times, 
phytochemicals from medicinal plants serve as lead compounds in drug discovery and design. 
Pharmacological studies have acknowledged the value of medicinal plants as potential source of 
bioactive compounds (Prusti et al., 2008). Medicinal plants are rich source of novel drugs that forms 
the ingredients in traditional systems of medicine, modern medicines, nutraceuticals, food 
supplements, folk medicines, pharmaceutical intermediates, bioactive principles and lead compounds 
in synthetic drugs (Ncube, 2008). WHO pointed out that more than 80% of world’s population depends 
on plants to meet their primary health care needs. However, overexploitation of the selected medicinal 
plant species lead to the reduction in number of plants in the wild and inclusion of their name in the red 
data book (Ahmedullah and Nayar 1999). In recent years, haphazard use of synthetic drugs has been 
reported to result in side effects that hamper the process of treatment. This drives the need to screen 
medicinal plants for novel bioactive compounds as plant based drugs are biodegradable, safe and have 
fewer side effects (Prusti et al., 2008). 
            Neem (Azadirachta indica A. Juss) is perhaps the most commonly used traditional medicinal 
plant of India. In India, Neem is known as "Divine Tree", "Heal All", “the village pharmacy”, because 
of its healing versatility, and it has been used by various traditional means of medicine due to its 
multiple medicinal properties. Almost all parts of the plant are endowed with medicinal property. 
During the past few decades, apart from studies on chemical properties of Neem compounds, 
considerable progress has been made in evaluating biological activity of Neem compounds for medical 
applications (Puri, 1999). In the modern era, Neem is considered as a store house of natural compounds 
that can potentially be exploited in the development of drugs against infectious diseases and systemic 
disorders. Neem plant has been reported to be endowed with biochemical compounds with wide range 
of biological activities and medicinal properties (Biswas et al., 2002). 
            Azadirachta indica A. Juss (syn. Melia azadirachta) is well known in India and its neighboring 
countries as one of the most versatile medicinal plants having a wide spectrum of biological activity. A. 
indica and M. azedarach are two closely related species of Meliaceae. The former is popularly known 
as Indian Neem (margosa tree) or Indian lilac, and the latter as the Persian lilac (Parrotta and 
Chaturvedi, 1994; Biswas et al., 2002). Neem is an evergreen tree, cultivated in various parts of the 
Indian subcontinent. Every part of the tree has been used as traditional medicine for household remedy 
against various human ailments, from antiquity. Several pharmacological activities and medicinal 
applications of various parts of Neem have been documented in the ancient literature.
Chemical investigation on Neem compounds have extensively been undertaken in the middle of 20th 
century. Since, the isolation of nimbin, (a bitter compound from Neem oil), in 1942 on more than 145 
compounds have been isolated from different parts of Neem. These compounds can be classified as 
isoprenoids and others. Isoprenoids include diterpenoids and triterpenoids containing protomeliacins, 
limonoids, azadirone and its derivatives, gedunin and its derivatives, vilasinin type and its derivatives 
and Csecomeliacins such as nimbin, salanin and azadirachtin. The non-isoprenoids include proteins 
(amino acids) and carbohydrates (polysaccharides), sulphurous compounds, polyphenolics such as 
flavonoids and their glycosides, dihydrochalcone, coumarin and tannins, aliphatic compounds, etc. 
Biological activities and medicinal properties of Neem compounds have been extensively reviewed by 
(Biswas et al., 2002).
Biological activities of various Neem compounds have been reported with crude extracts from leaf, 
bark, root, seed and oil (SaiRam et al., 2002; Thakurta et al., 2007; Rajasekaran et al., 2008). Neem 
has been extensively used in Ayurveda, Unani, Homoeopathic and Siddha medicine and has become a 
cynosure of modern medicine (Varma, 1976). However, only crude extract of different parts of Neem 
has been used as traditional medicine for the treatment of various diseases. For instance, inhibitory 
potential of Neem leaves on Dengue virus type-2 replication has been shown by Parida et al., (2002). 
The aqueous extract of Neem leaf was found to offer protection against paracetamol induced liver 
necrosis in rats. The elevated levels of serum aspartate aminotransferase (AST), alanine 
aminotransferase (ALT) and gamma glutamyl transpeptidase (GGT) indicative of liver damage were 
found to be significantly reduced on administration of the Neem leaf aqueous extract (Bhanwra et al., 
2000). In the present study we have evaluated the hepatoprotective role of A. indica.
MATERIALS AND METHODS
Collection of Plant Material
            Mature leaves of A. indica were collected from Vellore, Tamilnadu, India during Apr 2008. The 
Flora of Presidency of Madras (Gamble, 1935) and The Flora of Tamil Nadu Carnatic (Matthew, 1983) 
were used for identification and authentication of the plants. Collected material was washed thoroughly 
in running tap water, rinsed in distilled water and shade dried in open air and grounded into powder. 
Preparation of Phytochemical Extracts
            The leaves were dried under shade and coarsely powdered. The powder was successively 
extracted using soxhlet apparatus with ethanol and water. These extracts were condensed using rotary 
vacuum evaporator followed by vacuum evaporator and stored in desiccators. The powder of all the 
extracts was suspended in appropriate solvent systems and was subjected to further analysis. 
Experimental animals
            The cross breed albino mice weighing 20-25g were housed in clean propylene cages and 
maintained at 30±2oC under natural light/ dark conditions. They were fed with standard pellet diet and 
water was given ad libitum. The animals were acclimatized to laboratory conditions for 2 weeks. 
Animals were divided into seven groups of six mice each. The body weight of each of the animals was 
recorded initially. The period of experimentation was 5 days.
Carbon tetrachloride induced hepatotoxicity 
            Group I animals received 1% CMC in distilled water (2ml/ kg body weight) for five days with 
olive oil (2ml/kg body weight) on second and third day. Group II animals received 1% CMC (2ml/kg 
body weight) for 5 days with 1: 1 mixture of olive oil and CCl4 (2ml/kg body weight) on 2nd and 3rd 
day. Group III animals served as positive control and were given silymarin (200mg/kg) for five days. 
Group IV and Group V animals were given ethanolic extract of AM (500mg/kg) and (600mg/kg) body 
weight respectively. Group VI and Group VII animals received respectively 500mg/kg and 600mg/kg 
body aqueous extract of AM weight. In addition to ethanolic and aqueous extracts, 1:1 mixture of olive 
oil and CCl4 (2ml/kg body weight) were given to Group IV to Group VII animals on 2nd and 3rd day. 
Enzyme Assay
            On the fifth day, blood was collected from the retro orbital plexus of the animals and serum was 
allowed to coagulate at 370C for 30 min, and subjected to centrifugation at 2500 rpm. Serum samples 
were stored at 2-80C until further use. The enzyme assay was determined for Serum Glutamate 
Oxaloacetate Transaminase (SGOT), Serum Glutamate Pyruvate Transaminase (SGPT) (Reitman, 
1957), and Alkaline Phosphatase (ALP) (modified method of Kind, 1954) using commercially 
available enzyme kit (Crest Biosystems, Goa, India).
RESULTS AND DISCUSSION
            Levels in CCl4 induced hepatotoxicity with respect to SGOT, SGPT and ALP in mice using 
aqueous and ethanolic extracts of A. indica is given in Table 1. As compared to the control (61.3 ± 5.2, 
41.3 ± 2.9, 5.7 ± 0.4), CCl4 treated animals exhibited significantly higher levels of enzyme activities 
(142 ± 11.5a, 100 ± 8.7a, 12.0 ± 0.2a) in serum. Ethanolic extract (500 mg/kg) (91.3 ± 5.8c, 64.0 ± 2.3c, 
8.9 ± 0.5c) and AEE (600 mg/kg + CCl4) (90. 6 ± 5.4c, 62.3 ± 1.9c, 8.7 ± 0.4c) were found to have 
moderate activity as compared to silymarin (200 mg/kg + CCl4) 54 ± 5.7a, 35.3 ± 1.7a and 4.4 ± 0.3a 
for SGOT, SGPT and ALP respectively. Analysis of SGOT, SGPT and ALP levels in carbon 
tetrachloride induced hepatotoxicity in mice against aqueous and ethanolic extracts of A. indica 
revealed that ethanolic and aqueous extracts were moderately effective when compared to silymarin 
treatment. Further, the P<0.01 values in the case of AEE (500 mg/kg) was significant indicating that 
ethanolic extracts of A. indica holds a potential to be used as an hepatoprotective agent. 
Plants are known to have beneficial therapeutic effects documented in Traditional Indian System of 
Medicine. Off late, interest in a large number of traditional natural products has increased. Much work 
has been done on Neem in India. It has been suggested that phytochemical extracts from A. indica, can 
be used as potential source for antidiabetic, antitumoral and antimicrobial compounds (Rajasekaran et 
al., 2008). The results of the present study would certainly help to ascertain the potency of the crude 
extracts of Neem as potential source of natural hepatoprotective agents. Results indicate that ethanolic 
extracts of A. indica holds an impending to be used as a hepatoprotective agent. However, further 
research is needed to identify individual components responsible for hepatoprotective activity and 
develop their application for food and pharmaceutical industries. Further, the present study 
acknowledges the ethnobotanical uses and hepatoprotective nature of A. indica.
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Table 1. Analysis of hepatoprotective activity of leaf extracts of A. indica.
 
Group Treatment SGOT
(U/ml)
SGPT
(U/ml)
ALP
(KA units)
І Control (1% CMC) 61.3 ± 5.2 41.3 ± 2.9 5.7 ± 0.4
ІІ CCl4 treatment 142.0 ± 9.5a 100.0 ± 8.7a 12.0 ± 0.2a
ІІІ Silymarin (200 mg/
kg) + CCl4 54.0 ± 5.7a 35.3 ± 1.7a 4.4 ± 0.3a
ІV AEE (500 mg/kg) + 
CCl4 91.3± 5.8c 64.0± 2.3c 8.9 ± 0.5c
V AEE (600 mg/kg) + 
CCl4 90. 6 ± 5.4c 62.3 ± 1.9c 8.7 ± 0.4c
VI AAE (500 mg/kg) + 
CCl4 70.0 ± 3.0c 56.0 ± 1.1c 7.3 ± 0.1b
VII AAE (600 mg/kg) + 
CCl4 56.6± 6.5c 53.3±2.9c 5.5 ± 0.3b
Values are expressed in Mean ± SE for three animals in each group; aP<0.001; bP<0.01; cP<0.1.
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Fig. 1. Hepatoprotective activity of leaf extracts of Azadirachta indica.
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